Pharmaceutical Technology

MAY 2, 2023

IO agents include the classes of immune checkpoint modulators, cell therapies, bispecific antibodies, oncolytic viruses, therapeutic vaccines, and cytokines. Combining data from all markets, efficacy-related needs were identified as the most important unmet needs category. Cost-related unmet needs also scored highly.

Immunization 52

Immunization Vaccines 52

pharmaphorum

NOVEMBER 16, 2021

NICE notes in its final appraisal document (FAD) for the drug that many patients with this form of epilepsy may have to try a range of medicines, both alone and in combination, in order to control seizures. Epilepsy affects more than 600,000 people in the UK and for some, seizures can be life-threatening. .

Documentation 84

Documentation 84

pharmaphorum

JULY 25, 2022

The EMA’s human medicines committee has recommended approval of Johnson & Johnson’s Tecvayli as a fourth-line therapy for multiple myeloma , joining a growing group of BCMA-targeted therapies for the blood cancer.

FDA 52

FDA 52

European Pharmaceutical Review

AUGUST 24, 2022

An ADC combines the specificity of an antibody and the potent power of an anti?cancer 1 While the first successes underscored the potential of this class of targeted therapies, they also revealed bottle? Finding the right combination. cancer agent or disease-relevant toxin. Tubulis’ second technology platform is called Tub?tag

Compounding 85

Compounding Pharmaceutical Companies Pharmaceutical Companies 85

pharmaphorum

OCTOBER 29, 2021

Trodelvy has already established itself as a go-to therapy for TNBC patients whose disease has progressed after prior treatments, says Gilead, while Keytruda is approved as a first-line therapy for the cancer in combination with chemotherapy, in patients with PD-L1 scores of 10 or more. billion for the full year.

Chemotherapy 52

Chemotherapy FDA 52

The Checkup by Singlecare

DECEMBER 5, 2023

The #ozempic tag on TikTok has amassed over 1 billion views to date. Qsymia : This medication combines phentermine with the anti-seizure and migraine medication topiramate. Contrave (naltrexone-bupropion): Contrave is a combination of a substance abuse medication and an antidepressant that’s thought to regulate appetite in the brain.

Insurance 105

Insurance Prescription Filling FDA Dosage 105

pharmaphorum

JUNE 8, 2021

In a statement on the approval, ICER said the view of many experts was that current evidence is simply not enough to support the use of aducanumab in Alzheimer’s patients, and the FDA had “moved the goalposts” by not holding Biogen’s drug to the standards of other therapies.

FDA 98

FDA Labelling 98

The Checkup by Singlecare

NOVEMBER 2, 2023

The study assessed the effectiveness of combining Saxenda (liraglutide 3 mg) with intensive behavioral therapy (IBT) for obesity. These results highlight the potential of combining a GLP-1 agonist drug with IBT to achieve substantial weight loss. The high price tag is a barrier for many people. in the placebo group.

Insurance 52

Insurance FDA Adverse Reactions Hospitals 52

pharmaphorum

NOVEMBER 27, 2022

Incidents such as the hormone replacement therapy drug shortage in early 2022 have shown the damaging impact supply chain issues can have on people who depend on these drugs. To combat such challenges, pharmaceutical companies need to adopt processes that are not just efficient, but agile. About the author.

Communication 100

Communication Pharmaceutical Companies Pharmaceutical Companies Packaging 100

The Checkup by Singlecare

SEPTEMBER 7, 2023

Fortunately, drug therapy for diabetes has come a long way. Metformin has long been the first-line therapy for Type 2 diabetes. Many of these drugs can be taken in combination with each other for more resistant or complicated cases of diabetes, so one may already be on medication in one or more of these classes.

Insurance 52

Insurance Insurance Coverage FDA Dosage 52

The Spirit Pharmacist

DECEMBER 2, 2021

Psychedelic therapies are making headlines due to the unprecedented benefits demonstrated in clinical trials for persons with refractory mental illnesses. However, psychedelic assisted therapy is resource intensive and will likely come with a price tag putting it out of reach of many persons that could benefit from such therapies.

Health and Personal Care Stores 52

Health and Personal Care Stores Insurance Coverage Insurance Patient Care 52

The Checkup by Singlecare

MARCH 15, 2023

Breztri Aerosphere combines three medications used to prevent COPD attacks. Breztri Aerosphere combines three COPD maintenance medications: budesonide, glycopyrrolate, and formoterol. Other than Breztri Aerosphere, the only other combination triple therapy inhaler available in the U.S.

Insurance 52

Insurance Hospitals FDA 52

Pharmaceutical Technology

JANUARY 27, 2023

In an email to Pharmaceutical Technology , he further described the therapy as “the most important advance for treatment of TTP since the documentation of effectiveness of plasma exchange in 1991”. With these therapies, there is the possibility of there being no clinical benefit and an emergence of adverse events.

Documentation 52

Documentation Immunization Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

DECEMBER 2, 2020

US biotech TG Therapeutics has begun a rolling filing with the FDA for its combination therapy for chronic lymphocytic leukaemia, in a challenge to Roche. The New York-based firm has requested approval for the combination of its anti-CD20 antibody ublituximab and umralisib, an oral drug that inhibits PI3K-delta and CK-1 epsilon.

FDA 52

FDA Chemotherapy 52

The Checkup by Singlecare

AUGUST 30, 2023

Currently, efinaconazole topical is the most effective topical therapy forf toenail fungus, but there is no lower-priced generic version. How to get Jublia without insurance With a price tag reaching $10,000, 48 weeks of Jublia treatment may not be easy to fit into anyone’s budget. The post How much is Jublia without insurance?

Insurance 52

Insurance Insurance Coverage FDA 52

pharmaphorum

JUNE 15, 2021

The adoption of New Science – a unique combination of the best in science and health technology that address significant unmet patient needs – is delivering more precise and effective treatments, but often at a higher price tag, according to new research.

Vaccines 89

Vaccines 89

Roots Analysis

AUGUST 28, 2022

Recent advances in multi-omics approaches, including genomics, transcriptomics, proteomics, metabolomics, cytometry and imaging, in combination with bioinformatics and biostatistics, have been translated into several popular bioanalytical platforms, such as next-generation sequencing (NGS), single-cell analysis, flow cytometry and mass spectrometry.

52

52

pharmaphorum

DECEMBER 7, 2021

The researchers from the Cleveland Clinic discovered the association between Viagra and a lower risk of Alzheimer’s as part of a wide-ranging study that looked at more than 1,600 FDA-approved medicines to try to find drugs that could be re-purposed as dementia therapies.

Compounding 52

Compounding Insurance FDA 52

The Physician Pharmacist

SEPTEMBER 14, 2023

Hosted by licensed pharmacist and now 4th-year medical student Nathan Gartland, this podcast explores the unique pathway of combining pharmacy and medicine. This hands-on approach to medical care combines aspects of physical therapy and chiropractic, and is unique to osteopathic medicine. It's a lot of range of motion.

Medical Schools 52

Medical Schools Hospitals Communication Patient Care 52

STAT

DECEMBER 15, 2023

… Bluebird Bio claimed a large insurer has agreed to cover its newly approved sickle cell disease gene therapy, easing some investor worries about resistance from other payers over the high price of the treatment, Reuters says. But Bluebird’s $3.1

Insurance 94

Insurance FDA 94

Pharmaceutical Technology

NOVEMBER 30, 2022

We’re using a combination of gut hormones to mimic the effectiveness of bariatric surgery. In the first quarter since its launch as an approved therapy for type 2 diabetes, Mounjaro has proven to be a lucrative drug, making $97.3 Mounjaro is a combination of the two gut hormones GLP-1 and GIP. million in Q3. compared to a 5.1%

Insurance 105

Insurance Labelling Communication FDA 105

Pharmaceutical Technology

NOVEMBER 30, 2022

We’re using a combination of gut hormones to mimic the effectiveness of bariatric surgery. In the first quarter since its launch as an approved therapy for type 2 diabetes, Mounjaro has proven to be a lucrative drug, making $97.3 Mounjaro is a combination of the two gut hormones GLP-1 and GIP. million in Q3. compared to a 5.1%

Insurance 98

Insurance Labelling Communication FDA 98